| Tag | Content |
|---|
EnhancerAtlas ID | HS187-13714 |
Organism | Homo sapiens |
Tissue/cell | Th1 |
Coordinate | chr2:102636910-102637730 |
Target genes | |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| CTCF | MA0139.1 | chr2:102637247-102637266 | TGAACACTAGGGGGCAGCC | + | 6.49 | | SOX10 | MA0442.2 | chr2:102636943-102636954 | TTCTTTGTTTT | - | 6.62 | | ZNF263 | MA0528.1 | chr2:102637545-102637566 | GGAGGAGGGGAGGAAAAGGCG | + | 6.14 |
|
| | Number of super-enhancer constituents: 3 | ID | Coordinate | Tissue/cell |
| SE_44807 | chr2:102636977-102637643 | NHLF | | SE_45585 | chr2:102634481-102639286 | Osteoblasts | | SE_52672 | chr2:102637135-102637955 | Small_Intestine |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH02I102020 | chr2 | 102636681 | 102637862 |
|
Enhancer Sequence | ATCCTGGACT TTGCCTTGGA GAGTGGGCCA CACTTCTTTG TTTTTTATAC TGAATAATGA 60
TCACAACTGG GGTCTTTTGA GGGGATTTCA GAGAGCTTCA GAGACACGCT AAGTTTAAAT 120
AATTGGTCTA TAAGGGGAAA ATATATTTTT CTCACAGAGC ATCCAGAGAT TCAGTTGCAC 180
CGCATTTTCC CACGGACTGA GGTGTCCTGA TTGTGTTTGT TTTACAGTCC TGTGAGGATT 240
CGTTCATATC AGCTCCTTGC TTCTGGACAG GCCACTGACT CAGGTCTCCT GAGGCTTTCC 300
GTGGACCGGC ACGGTCCTGT CTCTGCGATA CTGTGCATGA ACACTAGGGG GCAGCCGCCC 360
TACATGCCTG TCTGTGTTGT GATCCTCCCA GGATCTCAGT GGCTCTCAAG GGGTGGTCCT 420
GGGCCAGCAG CGCCTCATCA CCTGGGTACT CAACAGACAT GCAAATCTCG GGTCCCGTGG 480
AGACCTACTG ATTGAAACTG GAGTCTGGGG GCTGTCATCT GTGTCTCACA AGCCCCCGGG 540
TGATGCTGGG GACCCTCAAG TCTAAGAAGC ACTGAGATCC TGGAGGCTTC TTTCTCTCCC 600
TGGATGCCCC AGCTCCATAG GGCAGCGCGT GACTTGGAGG AGGGGAGGAA AAGGCGTCTG 660
GCCGTGGTCG AAAAGCCGTC TGCCCCTCAG GCTGTCCTGC CATGCTGTCT AATGTGTACT 720
CATGTCAGGA TTTCAAAATG CTGTTTCGTG GAAGTGAGGA TGATGAGGCC CGTCGTGGAG 780
ACAACTCACA GCCCTCACCC CCCAGGTGTC CTTTTTGCTC 820
|
